Association Xtraordinaire
Menu icoMenu232White icoCross32White

Ajoutez un logo, un bouton, des réseaux sociaux

Cliquez pour éditer
icoFacebook24Color icoYoutube24Color icoInstagram24Color
  • Association Xtraordinaire
  • Histoire et projet ▴▾
    • NOTRE HISTOIRE
    • NOTRE PROJET
    • NOS ACTIONS RECHERCHES
    • NOS ACTIONS ASSOCIATIVES
    • TEMOIGNAGES
    • ILS NOUS SOUTIENNENT
    • CONTACT
    • PUBLICATIONS
    • PRIX XTRAORDINAIRE
    • CALENDRIER / SAVE THE DATES
  • Diagnostic ▴▾
    • Nouveau diagnostic
    • En attente de diagnostic
    • Troubles du neuro-développement
    • MALADIES LIÉES À L'X
    • Témoignages
    • Descriptions des symptomes et évolutions
  • Les syndromes Xtraordinaire ▴▾
    • Les mutations sur l'X
    • ARX
    • ATR-X
    • DDX3X
    • DTC - SLC6A8
    • MECP2
    • MCT8
    • PQBP1
    • RSK2 - SYNDROME DE COFFIN-LOWRY
    • Les autres mutations
  • NOUS SOUTENIR ▴▾
    • NOUS SOUTENIR
    • Donner
    • Boutique en ligne
  • Adhérer
  • Donner
  • Se connecter
  • NOTRE HISTOIRE
  • NOTRE PROJET
  • NOS ACTIONS RECHERCHES
  • NOS ACTIONS ASSOCIATIVES
  • TEMOIGNAGES
  • ILS NOUS SOUTIENNENT
  • CONTACT
  • PUBLICATIONS
  • PRIX XTRAORDINAIRE
  • CALENDRIER / SAVE THE DATES
  • Nouveau diagnostic
  • En attente de diagnostic
  • Troubles du neuro-développement
  • MALADIES LIÉES À L'X
  • Témoignages
  • Descriptions des symptomes et évolutions
  • Les mutations sur l'X
  • ARX
  • ATR-X
  • DDX3X
  • DTC - SLC6A8
  • MECP2
  • MCT8
  • PQBP1
  • RSK2 - SYNDROME DE COFFIN-LOWRY
  • Les autres mutations
  • NOUS SOUTENIR
  • Donner
  • Boutique en ligne

Creatine Transporter Deficiency (CTD / SLC6A8) is an X-linked syndrome caused by a mutation on the SLC6A8 gene. 

 

Creatine Transporter Deficiency is one of the 3 cerebral creatine deficiency syndromes (CCDS). It is a very rare genetic mutation on the X chromosome, that impairs the ability of the transporter to bring creatine into the brain cells. It affects mainly males but also females (+10%).

We estimate the number of current diagnosed patients around 500 in the world and about 100 in France, but we believe it is well under-diagnosed. 

The severity of CTD can vary from patient to patient but it generally causes neuro-developmental disorders. 
More common symptoms are (non-exhaustive list) :

Intellectual disability 

Speech delays

Learning disabilities

Autism   

Motor skills difficulties

Movement disorders

Hypotonia

Behavior disorders

Epilepsy, seizures

There is no treatment but there is promising research in the pipeline in France with Ceres Brain Therapeutics and in the US with Ultragenyx, and a lot of researchers and physicians trying to better understand the disease in order to find a cure.

The Commission for Creatine Transporter Deficiency (SLC6A8) represents almost 3/4 of the French CTD families, and has been crucial in initiating, funding, promoting research programs and upcoming therapeutic trials. Xtraordinaire CTD commission is also in contact with European CTD Families. 

Xtraordinaire has been partnering with the US Association for Creatine Deficiencies since 2016. https://creatineinfo.org/

You can contact us by email: creatine@xtraordinaire.org

 

LAST INTERNATIONAL CCDS (CTD, GAMT, AGAT) SYMPOSIUM IN PARIS (SEPT 29/30, 2023) 

Xtraordinaire CTD commission has organized its third international symposium on Creatine Transporter Deficiency In Paris on Friday, September 29 & Saturday, September 30, 2023. 

It was the opportunity to gather professionals and families/patients from around the world.

Themes : understanding clinical trials for rare disease, gene therapy, females with CTD, epilepsy, aging, siblings and families

All the videos of the symposium are available on our youtube channel @associationxtraordinaire

 

 

 

 

 

 

 

 

  • Plan du site
  • Licences
  • Mentions légales
  • CGUV
  • Paramétrer les cookies
  • Se connecter
  • Propulsé par AssoConnect, le logiciel des associations Caritatives